Kosan BioSciences -- KOSN | Stock Discussion Forums

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical
Kosan BioSciences -- KOSN

An SI Board Since May 2001

Posts	SubjectMarks	Bans	Symbol
933	40	0	KOSN

Emcee: tuck	Type: Unmoderated

Introduction Market Data Compact

Kosan's work with polyketides looks interesting. So I'm creating this thread to spare the T/FIF thread too much chatter on the subject. KOSN's lock-up expiration agreements expired over a month before this was written. The only sale to date by insiders was bought by other insiders in a private placement. The latter being a director and the CEO, so a nice sign of support.

Kosan's technology for manufacturing polyketides in quantity could provide a near term source of funding for their drug discovery programs.

Go to reply# or date (mm/dd/yy):

Reply	Message Preview	From	Recs	Posted
933	Kosan's Cancer Pipeline Attracts $5.50 Per Share BMS Buyout Bid By Jennifer	Icebrg	-	5/31/2008
932	Ixempra Is Not Enough? BMS Buys Kosan Posted: 29 May 2008 04:20 PM CDT [The InV	Icebrg	-	5/30/2008
931	OK, thanks for the thoughts/ideas. Rick	scaram(o)uche	-	5/29/2008
930	IDIX (by NVS) is a relatively likely one.	DewDiligence_on_SI	-	5/29/2008
929	I think the royalty is single digit. Been trying to find out but haven't got	rkrw	-	5/29/2008
928	>>What sort of royalty, etc., for cris?>> I really have no idea. Bu	Icebrg	-	5/29/2008
927	When I mimic your style, I generally win. Best! Rick	scaram(o)uche	-	5/29/2008
926	unfortunately, i did not double down as usual when she hit the lows this time.	mopgcw	-	5/29/2008
925	cool! congrats on the end, in any event. that's it, only two big winners?	scaram(o)uche	-	5/29/2008
924	What sort of royalty, etc., for cris? Who are the other players apart from exel	scaram(o)uche	-	5/29/2008
923	>> 2 or 3 franklins << I, hypothetical CEO of JNJ, spit in your gen	scaram(o)uche	-	5/29/2008
922	OT I run a bit of my Mom's high risk money. She has a long term time frame	tuck	-	5/29/2008
921	Kosan makes my day. ;-) I'm sitting in the Russian River Valley taking in	LJM	-	5/29/2008
920	Maybe CRIS by DNA MEDX by BMS COR by LLY or SGP Erik	Icebrg	-	5/29/2008
919	<Who is next? I'd buy Rigel for $2b, if they'd have me.> I can ki	kenhott	-	5/29/2008
918	hmmmm... your mom owns it and you don't. Maybe you can get your mom to post	kenhott	-	5/29/2008
917	your mom & me...(even at the same basis too!) alas it has been a long and b	mopgcw	-	5/29/2008
916	Yeah, I don't own any either. But, like Tuck, I have a relative in a bit of	scaram(o)uche	-	5/29/2008
915	Tip of the hat to management. Not only did they get a screaming premium, it look	Steve Lokness	-	5/29/2008
914	Helen S. Kim has delivered and earned her pay. Kosan's Board of Directors A	ejgopher	-	5/29/2008
913	If it makes you guys any happier, my Mom owned a little slug and will make not q	tuck	-	5/29/2008
912	My mistake, Roche dumped them, not Bristol.	rkrw	-	5/29/2008
911	Me no own any either. Who is next? This ain't stopping soon. The need is t	kenhott	-	5/29/2008
910	Interesting since Bristol had dumped their epothilone jv agreement last year! Un	rkrw	-	5/29/2008
909	$5.50/share (cash), munched by BMY.	scaram(o)uche	-	5/29/2008

Go to reply# or date (mm/dd/yy):